| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.953 | 12.879 | 13.397 | 76.832 | 130.908 | 113.757 | 73.604 | 16.392 | 17.660 | 17.298 |
| Total Income - EUR | 15.953 | 12.879 | 13.397 | 80.155 | 131.138 | 114.905 | 73.642 | 17.405 | 18.002 | 17.300 |
| Total Expenses - EUR | 7.245 | 2.162 | 3.026 | 84.905 | 134.728 | 114.731 | 71.883 | 6.964 | 7.713 | 5.793 |
| Gross Profit/Loss - EUR | 8.708 | 10.717 | 10.371 | -4.749 | -3.590 | 175 | 1.760 | 10.442 | 10.289 | 11.507 |
| Net Profit/Loss - EUR | 8.227 | 10.330 | 9.968 | -5.558 | -4.902 | -1.130 | 928 | 9.930 | 8.863 | 9.935 |
| Employees | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 0 | 0 | 0 |
Check the financial reports for the company - Medmarys Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 671 | 601 | 591 | 6.095 | 5.015 | 3.717 | 2.642 | 1.655 | 493 | 368 |
| Current Assets | 8.584 | 10.902 | 11.571 | 7.557 | 4.787 | 5.535 | 3.071 | 10.543 | 11.925 | 27.454 |
| Inventories | 1.044 | 1.033 | 0 | 4.734 | 3.379 | 4.057 | 0 | 0 | 0 | 0 |
| Receivables | 94 | 185 | 1.785 | 0 | 0 | 0 | 1.941 | 6.467 | 5.452 | 12.449 |
| Cash | 7.446 | 9.683 | 9.786 | 2.823 | 1.408 | 1.478 | 1.130 | 4.076 | 6.473 | 15.005 |
| Shareholders Funds | 8.491 | 10.591 | 10.225 | 4.479 | -509 | -1.630 | -208 | 7.714 | 10.742 | 20.616 |
| Social Capital | 142 | 140 | 138 | 135 | 133 | 130 | 127 | 128 | 127 | 127 |
| Debts | 764 | 911 | 1.937 | 9.172 | 10.311 | 10.882 | 5.920 | 4.484 | 1.677 | 7.206 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4615 - 4615" | |||||||||
| CAEN Financial Year |
4615
|
|||||||||
Comments - Medmarys Srl